Category: Medications - Page 5

How to Read Pregnancy and Lactation Labeling on Drugs: A Clear Guide to the FDA’s New System

How to Read Pregnancy and Lactation Labeling on Drugs: A Clear Guide to the FDA’s New System

Dec 18 2025 / Medications

Learn how to read the FDA's updated pregnancy and lactation drug labels that replaced outdated letter categories. Get clear guidance on understanding risks, breastfeeding safety, and what to ask your doctor.

VIEW MORE
Generic Medications: How They Save Patients Money Without Compromising Care

Generic Medications: How They Save Patients Money Without Compromising Care

Dec 17 2025 / Medications

Generic medications save patients up to 85% on prescription costs without sacrificing effectiveness. Learn how they work, why they're safe, and how to get them for less than $5 a month.

VIEW MORE
Doctor's Letter for Controlled Substances During International Travel: What You Need to Know

Doctor's Letter for Controlled Substances During International Travel: What You Need to Know

Dec 15 2025 / Medications

A doctor's letter for controlled substances is required for international travel with medications like Adderall, Xanax, or oxycodone. Learn what must be included, which countries have strict rules, and how to avoid detention at customs.

VIEW MORE
How to Build a Personal Medication Safety Plan with Your Care Team

How to Build a Personal Medication Safety Plan with Your Care Team

Dec 8 2025 / Medications

Build a personal medication safety plan with your care team to avoid dangerous errors, drug interactions, and missed doses. Learn how to track, store, and review your meds safely every day.

VIEW MORE
Slow Up-Titration Schedules: How Gradual Dose Increases Build Tolerance to Side Effects

Slow Up-Titration Schedules: How Gradual Dose Increases Build Tolerance to Side Effects

Dec 7 2025 / Medications

Slow up-titration schedules help your body adjust to new medications by gradually increasing doses over weeks or months. This reduces side effects and improves long-term adherence, especially for drugs like GLP-1 agonists and beta-blockers.

VIEW MORE
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Dec 6 2025 / Medications

The FDA monitors generic drugs after approval using real-world data, adverse event reports, and inspections to catch safety issues that clinical trials miss. Learn how systems like FAERS and Sentinel protect patients every day.

VIEW MORE
When Doctors Adjust Doses After Switching to Generic Medications

When Doctors Adjust Doses After Switching to Generic Medications

Dec 5 2025 / Medications

Switching to generic medications can be safe-but for drugs with a narrow therapeutic index, even small changes in absorption can require dose adjustments. Learn which meds need extra care and what to watch for after a switch.

VIEW MORE
Anticoagulation in Kidney and Liver Disease: What Doctors Really Do

Anticoagulation in Kidney and Liver Disease: What Doctors Really Do

Dec 4 2025 / Medications

Managing blood thinners in kidney and liver disease is complex. Apixaban is often the safest option, but decisions depend on kidney function, liver stage, platelet counts, and bleeding history. No guidelines cover all cases-so what doctors do matters most.

VIEW MORE
Corticosteroid-Induced Hyperglycemia and Diabetes: How to Monitor and Manage It

Corticosteroid-Induced Hyperglycemia and Diabetes: How to Monitor and Manage It

Dec 1 2025 / Medications

Corticosteroid-induced hyperglycemia affects up to 50% of patients on high-dose steroids. Learn how to monitor blood sugar, when to start insulin, and why tapering can cause dangerous lows.

VIEW MORE
Effective Patent Life: Why Market Exclusivity for Drugs Is Shorter Than You Think

Effective Patent Life: Why Market Exclusivity for Drugs Is Shorter Than You Think

Dec 1 2025 / Medications

Effective patent life for drugs is often just 10-13 years, not 20, due to long approval times. Secondary patents and regulatory exclusivities extend exclusivity beyond the original patent, creating complex market dynamics.

VIEW MORE